Phenotypic variation of familial hypertrophic cardiomyopathy caused by the Phe110 → Ile mutation in cardiac troponin T

Cardiology

Volumn 93, Issue 3, 2000, Pages 155-162

  Lin, Tong Lang ^a   Ichihara, Sahoko ^a   Yamada, Yoshiji ^b   Nagasaka, Tetsuo ^a   Ishihara, Hitoshi ^c   Nakashima, Nobuo ^a   Yokota, Mitsuhiro ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^c Okazaki City Hospital   (Japan)

Author keywords

Cardiac hypertrophy; Familial hypertrophic cardiomyopathy; Gene dosage effect; Japanese; Mutation; Troponin T

Indexed keywords

TROPONIN T;

AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; GENE DOSAGE; GENE MUTATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; JAPAN; MALE; PEDIGREE; PRIORITY JOURNAL;

EID: 0033798520     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007020     Document Type: Article

References (38)

1. Maron BJ, Bonow RO, Cannon RO III, Leon MB, Epstein SE: Hypertrophic cardiomyopathy: Interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med 1987;316:780-789.
2. Marian AJ, Roberts R: Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation 1995;92:1336-1347.
3. Schwartz K, Carrier L, Guicheney P, Komajda M: Molecular basis of familial cardiomyopathies. Circulation 1995;91:532-540.
4. Maron BJ, Epstein SE, Roberts WC: Cause of sudden death in competitive athletes. J Am Coll Cardiol 1986;7:204-214.
5. Geisterfer-Lawiance AAT, Kass S, Tanigawa G, Vosberg HP, McKenna W, Seidman CE, Seidman JG: A molecular basis for familial hypertrophic cardiomyopathy: β-Cardiac myosin heavy chain gene missense mutation. Cell 1990;62:999-1006.
6. Watkins H, Rosenzwcig A, Hwang DS, Levi T, McKenna W, Seidman CE, Seidman JG: Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 1992;326: 1108-1114.
7. Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg H-P, Seidman JG, Seidman CE: α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere. Cell 1994;77:701-712.
8. Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O'Donoghue A, Spiritp P, Matsumori A, Moravce CS, Seidman JC, Seidman CE: Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995;332:1058-1064.
9. Watkins H, Conner D, Thierfelder L, Jarcho JA, MacRae C, McKenna WJ, Maron BJ, Seidman JG, Seidman CE: Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet 1995;11:434-437.
10. Bonne G, Carrier L, Bercoviei J, Cruaud C, Richard P, Hainque B, Gautel M, Labeit S, James M, Beckmann J, Weissenbach J, Vosberg H-P, Fiszman M, Komajda M, Schwartz K: Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet 1995;11:438-440.
11. Kimura A, Harada H, Park J-E, Nishi H, Satoh M, Takahashi M, Hiroi S, Sasaoka T, Ohbuchi N, Nakamura T, Koyanagi T, Hwang T-H, Choo J-A, Chung K-S, Hasegawa A, Nagai R, Okazaki O, Nakamura H, Matsuzaki M, Sakamoto T, Toshima H, Koga Y, Imaizumi T, Sasazuki T: Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 1997;16:379-382.
12. Poetter K, Jiang H, Hassanzadeh S, Master SR, Chang A, Dalakas MC, Rayment I, Sellers JR, Fananapazir L, Epstein ND: Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet 1996;13:63-69.
13. Mogensen J, Klausen IC, Pedersen AK, Egeblad H, Bross P, Kruse TA, Gregersen N, Hansen PS, Baandrup U, Børglum AD: α-Cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. J Clin Invest 1999; 103:R39-R43.
14. Forissier J-D, Carrier L, Farza H, Bonne G, Bercovici J, Richard P, Hainque B, Townsend PJ, Yacoub MH, Fauré S, Dubourg O, Mallaire A, Hagège AA, Desnos M, Komajda M, Schwartz K: Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy. Circulation 1996;94:3069-3073.
15. Mootman JC, Corfield VA, Posen B, Ngumbela K, Seidman C, Brink PA, Watkins H: Sudden death due to troponin T mutations. J Am Coll Cardiol 1997;29:549-555.
16. Nakajima-Taniguchi C, Matsui H, Fujio Y, Nagata S, Kishimoto T, Yamauchi-Takihara K: Novel missense mutation in cardiac troponin T gene found in Japanese patients with hypertrophic cardiomyopathy. J Mol Cell Cardiol 1997;29:839-843.
17. Pearlstone JP, Carpenter MR, Smilie LB: Amino acid sequence of rabbit cardiac troponin T. J Biol Chem 1986;261:16795-16810.
18. Anan R, Dhono H, Kisanuki A, Arima S, Nakao S, Tanaka H: Patients with familial hypertrophic cardiomyopathy caused by a Phe110Ile missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favorable prognosis. Circulation 1998;98:391-397.
19. Surawiez B, Uhley H, Borun R: Task Force 1: Standardization of terminology and interpretation. Am J Cardiol 1978;41:130-145.
20. Feigenbaum H: Echocardiography. Philadelphia. Lea & Febiger, 1994.
21. Prakash R, Matskubo H: Usefulness of echocardiographic right ventricular measurements in estimating right ventricular hypertrophy and right ventricular systolic pressure. Am J Cardiol 1983;51:1036-1040.
22. Maron BJ, Wolfson JK, Ciro E, Spirito P: Relation of echocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in pathiets with hypetrophic cardiomyopathy. Am J Cardiol 1983;51:189-194.
23. Lever HM, Karam RF, Currie PJ, Healy BP: Hypertrophic cardiomyopathy in the elderly: Distinctions from the young based on cardiac shape. Circulation 1989;79:580-589.
24. 994→T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with genetic susceptibility to nonfamilial dilated cardiomyopathy in Japanese. Circulation 1998;98:1881-1885.
25. Mesnard L, Samson F, Espinasse I, Durand J, Neveux J-Y, Mercadier J-J: Molecular cloning and developmental expression of human cardiac troponin T, FEBS Lett 1993;328:139-144.
26. Jin JP, Huang QQ, Yeh HI, Lin JJ: Complete nucleotide sequence and structural organization of rat cardiac troponin T gene: A single gene generates embryonic and adult isoforms via developmentally regulated alternative splicing. J Mol Biol 1992;227:1269-1276.
27. Yokota M, Miyahara T, Iwase M, Watanabe M, Matsunami T, Kamihara S, Koide M, Saito H, Takeuchi J: Hemodynamic mechanisms of antianginal action of calcium channel blocker nisoldipine in dynamic exercise-induced angina. Circulation 1990;81:1887-1898.
28. Izawa H, Yokota M, Takeichi Y, Inagaki M, Nagata K, Iwase M, Sobue T: Adrenergic control of the force-frequency and relaxation-frequency relations in patients with hypertrophic cardiomyopathy. Circulation 1997;96:2959-2968.
29. Townsend PJ, Farza H, MacGeon C, Spurr NK, Wade R, Gahlmann R, Yacoub MH, Barton PJR: Human cardiac troponin T: Identification of fetal isoforms and assignment of the TNNT2 locus to chromosome 1q. Genomics 1994;21:311-316.
30. Zot AS, Potter JD: Structure aspects of troponin-tropomyosin regulation of skeletal muscle contraction. Annu Rev Biochem 1987;16:535-559.
31. Watkins H, Seidman CE, Seidman JG, Feng HS, Sweeney HL: Expression and functional assessment of a truncated cardiac troponin T that causes hyertrophic cardiomyopathy. J Clin Invest 1996;98:2456-2461.
32. Sweeney HL, Feng HS, Yang Z, Watkins H: Functional analysis of troponin T mutations that cause hypertrophic cardiomyopathy: Insights into disease pathogenesis and troponin function. Proc Natl Acad Sci USA 1998;95: 14406-14410.
33. Koga Y, Toshima H, Kimura A, Harada H, Koyanagi T, Nishi H, Nakata M, Imaizumi T: Clinical manifestations of hypertrophic cardiomyopathy with mutations in the cardiac betamyosin heavy chain gene or cardiac troponin T gene. J Card Fail 1996;2:(suppl 4):97-103.
34. Epstein ND, Cohn GM, Cyran F, Fananapazir L: Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the β-myosin heavy chain gene: A 908Leu→Val mutation and a 403Arg→Glu mutation. Circulation 1992;86: 345-352.
35. Greaves SC, Roche AHG, Neutze JM, Whitlock RML, Veale AM: Inheritance of hypertrophic cardiomyopathy: A cross-sectional and M mode echocardiographic study of 50 families. Br Heart J 1987;58:259-266.
36. Rosenzweig A, Watkins H, Hwang DS, Miri M, McKenna W, Traill TA, Seidman JG, Seidman CE: Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes. N Engl J Med 1995;325: 1058-1064.
37. Watkins H, Seidman JG, Seidman CE: Familial hypertrophic cardiomyopathy: A genetic model of cardiac hypertrophy. Hum Mol Genet 1995;4:1721-1727.
38. Nishi H, Kimura A, Harada H, Adachi K, Koga Y, Sasazuki T, Toshima H: Possible gene dose effect of a mutant cardiac β-myosin heavy chain gene on the clinical expression of familial hypertrophic cardiomyopathy. Biochem Biophys Res Commun 1994;200:549-556.